Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of GABA Receptor Agonist Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of GABA Receptor Agonist Drugmarket, defines the market attractiveness level of GABA Receptor Agonist Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of GABA Receptor Agonist Drug industry, describes the types of GABA Receptor Agonist Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global GABA Receptor Agonist Drug market and the development prospects and opportunities of GABA Receptor Agonist Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global GABA Receptor Agonist Drug market in Chapter 13.
By Player:
Novartis
Elan Corporation
AstraZeneca
VIVUS
XenoPort
GlaxoSmithKline
HLundBeck, Merck and Co
OVATION Pharmaceuticals
NovaDel Pharma
sanofi-aventis
Pfizer
Osmotica Pharmaceutical
Advicenne
Biocodex
Eli Lilly and Company
Athena Drug Delivery Solutions
By Type:
Bamaluzole
Phenibut
Baclofen
Gaboxadol
Klonopin (clonazepam)
Tiagbine
By End-User:
Attention Deficit Hyperactivity Disorder (ADHD)
Psychiatric Disorders and Depression
Alzheimer
Epilepsy and Seizure
Anxiety and Sleep Disorders
Obesity and Alcoholism
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 GABA Receptor Agonist Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 GABA Receptor Agonist Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 GABA Receptor Agonist Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 GABA Receptor Agonist Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise GABA Receptor Agonist Drug Market Analysis and Outlook to 2022
-
7.1 Global GABA Receptor Agonist Drug Consumption (2017-2022)
-
7.2 United States GABA Receptor Agonist Drug Consumption (2017-2022)
-
7.3 Europe GABA Receptor Agonist Drug Consumption (2017-2022)
-
7.4 China GABA Receptor Agonist Drug Consumption (2017-2022)
-
7.5 Japan GABA Receptor Agonist Drug Consumption (2017-2022)
-
7.6 India GABA Receptor Agonist Drug Consumption (2017-2022)
-
7.7 South Korea GABA Receptor Agonist Drug Consumption (2017-2022)
8 Region and Country-wise GABA Receptor Agonist Drug Market Analysis and Outlook to 2028
-
8.1 Global GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
8.2 United States GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
8.3 Europe GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
8.4 China GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
8.5 Japan GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
8.6 India GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
-
8.7 South Korea GABA Receptor Agonist Drug Consumption Forecast (2022-2028)
9 Global GABA Receptor Agonist Drug Market Outlook by Types and Applications to 2022
-
9.1 Global GABA Receptor Agonist Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Bamaluzole Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Phenibut Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Baclofen Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Gaboxadol Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Klonopin (clonazepam) Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Tiagbine Consumption and Growth Rate (2017-2022)
-
9.2 Global GABA Receptor Agonist Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Psychiatric Disorders and Depression Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Alzheimer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Epilepsy and Seizure Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Anxiety and Sleep Disorders Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Obesity and Alcoholism Consumption and Growth Rate (2017-2022)
10 Global GABA Receptor Agonist Drug Market Outlook by Types and Applications to 2028
-
10.1 Global GABA Receptor Agonist Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Bamaluzole Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Phenibut Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Baclofen Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Gaboxadol Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Klonopin (clonazepam) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Tiagbine Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global GABA Receptor Agonist Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Psychiatric Disorders and Depression Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Alzheimer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Epilepsy and Seizure Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Anxiety and Sleep Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Obesity and Alcoholism Consumption Forecast and Growth Rate (2022-2028)
11 Global GABA Receptor Agonist Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global GABA Receptor Agonist Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global GABA Receptor Agonist Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 GABA Receptor Agonist Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global GABA Receptor Agonist Drug Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis GABA Receptor Agonist Drug Product and Service
-
14.2 Elan Corporation
-
14.2.1 Elan Corporation Company Details
-
14.2.2 Elan Corporation GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Elan Corporation GABA Receptor Agonist Drug Product and Service
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Details
-
14.3.2 AstraZeneca GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AstraZeneca GABA Receptor Agonist Drug Product and Service
-
14.4 VIVUS
-
14.4.1 VIVUS Company Details
-
14.4.2 VIVUS GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 VIVUS GABA Receptor Agonist Drug Product and Service
-
14.5 XenoPort
-
14.5.1 XenoPort Company Details
-
14.5.2 XenoPort GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 XenoPort GABA Receptor Agonist Drug Product and Service
-
14.6 GlaxoSmithKline
-
14.6.1 GlaxoSmithKline Company Details
-
14.6.2 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 GlaxoSmithKline GABA Receptor Agonist Drug Product and Service
-
14.7 HLundBeck, Merck and Co
-
14.7.1 HLundBeck, Merck and Co Company Details
-
14.7.2 HLundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 HLundBeck, Merck and Co GABA Receptor Agonist Drug Product and Service
-
14.8 OVATION Pharmaceuticals
-
14.8.1 OVATION Pharmaceuticals Company Details
-
14.8.2 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Product and Service
-
14.9 NovaDel Pharma
-
14.9.1 NovaDel Pharma Company Details
-
14.9.2 NovaDel Pharma GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 NovaDel Pharma GABA Receptor Agonist Drug Product and Service
-
14.10 sanofi-aventis
-
14.10.1 sanofi-aventis Company Details
-
14.10.2 sanofi-aventis GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 sanofi-aventis GABA Receptor Agonist Drug Product and Service
-
14.11 Pfizer
-
14.11.1 Pfizer Company Details
-
14.11.2 Pfizer GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Pfizer GABA Receptor Agonist Drug Product and Service
-
14.12 Osmotica Pharmaceutical
-
14.12.1 Osmotica Pharmaceutical Company Details
-
14.12.2 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Product and Service
-
14.13 Advicenne
-
14.13.1 Advicenne Company Details
-
14.13.2 Advicenne GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Advicenne GABA Receptor Agonist Drug Product and Service
-
14.14 Biocodex
-
14.14.1 Biocodex Company Details
-
14.14.2 Biocodex GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Biocodex GABA Receptor Agonist Drug Product and Service
-
14.15 Eli Lilly and Company
-
14.15.1 Eli Lilly and Company Company Details
-
14.15.2 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Eli Lilly and Company GABA Receptor Agonist Drug Product and Service
-
14.16 Athena Drug Delivery Solutions
-
14.16.1 Athena Drug Delivery Solutions Company Details
-
14.16.2 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of GABA Receptor Agonist Drug
-
Figure GABA Receptor Agonist Drug Picture
-
Table Global GABA Receptor Agonist Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global GABA Receptor Agonist Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global GABA Receptor Agonist Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global GABA Receptor Agonist Drug Consumption by Country (2017-2022)
-
Figure United States GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Table Europe GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure China GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure India GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea GABA Receptor Agonist Drug Consumption and Growth Rate (2017-2022)
-
Figure Global GABA Receptor Agonist Drug Consumption Forecast by Country (2022-2028)
-
Figure United States GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea GABA Receptor Agonist Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bamaluzole Consumption and Growth Rate (2017-2022)
-
Figure Global Phenibut Consumption and Growth Rate (2017-2022)
-
Figure Global Baclofen Consumption and Growth Rate (2017-2022)
-
Figure Global Gaboxadol Consumption and Growth Rate (2017-2022)
-
Figure Global Klonopin (clonazepam) Consumption and Growth Rate (2017-2022)
-
Figure Global Tiagbine Consumption and Growth Rate (2017-2022)
-
Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption and Growth Rate (2017-2022)
-
Figure Global Psychiatric Disorders and Depression Consumption and Growth Rate (2017-2022)
-
Figure Global Alzheimer Consumption and Growth Rate (2017-2022)
-
Figure Global Epilepsy and Seizure Consumption and Growth Rate (2017-2022)
-
Figure Global Anxiety and Sleep Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Obesity and Alcoholism Consumption and Growth Rate (2017-2022)
-
Figure Global Bamaluzole Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phenibut Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Baclofen Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gaboxadol Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Klonopin (clonazepam) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tiagbine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psychiatric Disorders and Depression Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alzheimer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Epilepsy and Seizure Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anxiety and Sleep Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Obesity and Alcoholism Consumption Forecast and Growth Rate (2022-2028)
-
Table Global GABA Receptor Agonist Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global GABA Receptor Agonist Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis GABA Receptor Agonist Drug Product and Service
-
Table Elan Corporation (Foundation Year, Company Profile and etc.)
-
Table Elan Corporation GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Elan Corporation GABA Receptor Agonist Drug Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca GABA Receptor Agonist Drug Product and Service
-
Table VIVUS (Foundation Year, Company Profile and etc.)
-
Table VIVUS GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table VIVUS GABA Receptor Agonist Drug Product and Service
-
Table XenoPort (Foundation Year, Company Profile and etc.)
-
Table XenoPort GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table XenoPort GABA Receptor Agonist Drug Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline GABA Receptor Agonist Drug Product and Service
-
Table HLundBeck, Merck and Co (Foundation Year, Company Profile and etc.)
-
Table HLundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table HLundBeck, Merck and Co GABA Receptor Agonist Drug Product and Service
-
Table OVATION Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table OVATION Pharmaceuticals GABA Receptor Agonist Drug Product and Service
-
Table NovaDel Pharma (Foundation Year, Company Profile and etc.)
-
Table NovaDel Pharma GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table NovaDel Pharma GABA Receptor Agonist Drug Product and Service
-
Table sanofi-aventis (Foundation Year, Company Profile and etc.)
-
Table sanofi-aventis GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table sanofi-aventis GABA Receptor Agonist Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer GABA Receptor Agonist Drug Product and Service
-
Table Osmotica Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Osmotica Pharmaceutical GABA Receptor Agonist Drug Product and Service
-
Table Advicenne (Foundation Year, Company Profile and etc.)
-
Table Advicenne GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advicenne GABA Receptor Agonist Drug Product and Service
-
Table Biocodex (Foundation Year, Company Profile and etc.)
-
Table Biocodex GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocodex GABA Receptor Agonist Drug Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company GABA Receptor Agonist Drug Product and Service
-
Table Athena Drug Delivery Solutions (Foundation Year, Company Profile and etc.)
-
Table Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product and Service
-
